650 total citations 19 papers, 566 citations indexed
About
Da Prada M is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Neurology.
According to data from OpenAlex, Da Prada M has authored 19 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Da Prada M's work include Pharmacology and Obesity Treatment (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Da Prada M is often cited by papers focused on Pharmacology and Obesity Treatment (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Da Prada M collaborates with scholars based in Switzerland. Da Prada M's co-authors include G. Zürcher, R. Kettler, A. Pletscher, L. Pieri, J. Borgulya, R. Schaffner, Margherita Pieri, R. Scherschlicht, P. Polc and Arnold B. Davidson and has published in prestigious journals such as Inflammation Research and PubMed.
In The Last Decade
Da Prada M
19 papers
receiving
535 citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Da Prada M's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da Prada M with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da Prada M more than expected).
This network shows the impact of papers produced by Da Prada M. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da Prada M. The network helps show where Da Prada M may publish in the future.
Co-authorship network of co-authors of Da Prada M
This figure shows the co-authorship network connecting the top 25 collaborators of Da Prada M.
A scholar is included among the top collaborators of Da Prada M based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Da Prada M. Da Prada M is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
19 of 19 papers shown
1.
Zürcher, G., et al.. (1990). Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats.. PubMed. 53. 497–503.76 indexed citations
2.
Kettler, R., et al.. (1990). Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans.. PubMed. 53. 505–12.25 indexed citations
3.
M, Da Prada, et al.. (1989). Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.. PubMed. 28. 5–20.31 indexed citations
4.
M, Da Prada, et al.. (1988). On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.. PubMed. 26. 31–56.157 indexed citations
5.
M, Da Prada, et al.. (1987). Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.. PubMed. 45. 175–8.17 indexed citations
6.
M, Da Prada & R. Kettler. (1986). Uptake, metabolism and subcellular localization of MPTP and MPP+ in blood platelets.. PubMed. 9 Suppl 4. 347–9.1 indexed citations
7.
M, Da Prada, et al.. (1983). [Hermansky-Pudlak syndrome in a Valais village].. PubMed. 38(5-6). 495–512.7 indexed citations
8.
Schaffner, R., et al.. (1982). Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine.. PubMed. 31. 249–63.12 indexed citations
9.
M, Da Prada, et al.. (1982). Some neuropharmacological effects of Ro 11-2465--a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT.. PubMed. 31. 235–48.9 indexed citations
10.
Pieri, L., R. Schaffner, R. Scherschlicht, et al.. (1981). Pharmacology of midazolam.. PubMed. 31(12a). 2180–201.127 indexed citations
11.
M, Da Prada, et al.. (1980). Cytochemical investigations on subcellular organelles storing biogenic amines in peripheral adrenergic neurons.. PubMed. 25. 269–78.5 indexed citations
12.
Pieri, L., et al.. (1978). Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.. PubMed. 19. 393–6.4 indexed citations
13.
Pieri, Maria, L. Pieri, A. Saner, Da Prada M, & W Haefely. (1975). A comparison of drug-induced rotation in rats lesioned in the medial forebrain bundle with 5,6-dihydroxytryptamine or 6-hydroxydopamine.. PubMed. 217(1). 118–30.22 indexed citations
14.
Pletscher, A., et al.. (1974). Molecular organization of amine storage organelles of blood platelets and adrenal medulla.. PubMed. 2. 257–64.22 indexed citations
15.
M, Da Prada & A. Pletscher. (1974). Mechanisms of 5-hydroxytryptamine storage in subcellular organelles of blood platelets.. PubMed. 10. 311–20.10 indexed citations
16.
Pletscher, A., et al.. (1970). A biophysical model for the storage and release of biogenic monoamines at the level of the storage organelles.. PubMed. 2. 205–11.3 indexed citations
Pletscher, A., et al.. (1968). Metabolism, subcellular transport and storage of 5-hydroxytryptamine in blood platelets.. PubMed. 46(3). 399–406.9 indexed citations
19.
Pletscher, A., et al.. (1966). [The increase of 5-hydroxytryptamine in submicroscopic organelles of blood platelets].. PubMed. 68. C108–10.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.